Allergic vasculitis associated with celecoxib
Allergic vasculitis associated with celecoxib
SIR, The new cyclooxygenase 2 (COX-2)-specific non-steroidal anti-inflammatory drugs (NSAIDs) are being used with increasing frequency. Cutaneous vasculitis associated with the COX-2-specific NSAID celecoxib (Celebrex) is not well documented. Following the recent report of fatal allergic vasculitis associated with celecoxib described in Lancet [1], we report a case of non-fatal allergic vasculitis associated with celecoxib.
In March 2002, a 69-yr-old Caucasian lady had been prescribed celecoxib for knee osteoarthritis; she took a daily dose of 200 mg for 1 week with no problems and then discontinued the drug as her pain had improved significantly. She then re-introduced the medication herself approximately 10 days later for the same pain. Seven days after re-introduction of celecoxib, she developed a maculopapular rash affecting both lower legs and feet. Celecoxib was discontinued. The rash developed into non-blanching purpuric lesions that ulcerated (Fig. 1), particularly over the feet, and the patient also developed necrotic ulcers on the posterior aspect of her right calf and on her feet. She was admitted to hospital at this stage for investigation.
1453-1455
Jordan, K.M.
80de2e5f-cf7e-4f63-8418-ad75781bda96
Edwards, C.J.
dcb27fec-75ea-4575-a844-3588bcf14106
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
2002
Jordan, K.M.
80de2e5f-cf7e-4f63-8418-ad75781bda96
Edwards, C.J.
dcb27fec-75ea-4575-a844-3588bcf14106
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Abstract
SIR, The new cyclooxygenase 2 (COX-2)-specific non-steroidal anti-inflammatory drugs (NSAIDs) are being used with increasing frequency. Cutaneous vasculitis associated with the COX-2-specific NSAID celecoxib (Celebrex) is not well documented. Following the recent report of fatal allergic vasculitis associated with celecoxib described in Lancet [1], we report a case of non-fatal allergic vasculitis associated with celecoxib.
In March 2002, a 69-yr-old Caucasian lady had been prescribed celecoxib for knee osteoarthritis; she took a daily dose of 200 mg for 1 week with no problems and then discontinued the drug as her pain had improved significantly. She then re-introduced the medication herself approximately 10 days later for the same pain. Seven days after re-introduction of celecoxib, she developed a maculopapular rash affecting both lower legs and feet. Celecoxib was discontinued. The rash developed into non-blanching purpuric lesions that ulcerated (Fig. 1), particularly over the feet, and the patient also developed necrotic ulcers on the posterior aspect of her right calf and on her feet. She was admitted to hospital at this stage for investigation.
This record has no associated files available for download.
More information
Published date: 2002
Additional Information:
Letters to the Editor
Identifiers
Local EPrints ID: 25676
URI: http://eprints.soton.ac.uk/id/eprint/25676
ISSN: 1462-0324
PURE UUID: 7ddb2514-6677-456e-bff8-0742435dd157
Catalogue record
Date deposited: 21 Apr 2006
Last modified: 15 Mar 2024 07:04
Export record
Altmetrics
Contributors
Author:
K.M. Jordan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics